Cutler Group LP Deciphera Pharmaceuticals, Inc. Call Options Transaction History

Cutler Group LP

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 Apr 19, 2024	BUY	$13.58 - $17.36 $4,074 - $5,208	300 Added 150.0%	500 $0
Q4 2023 Jan 18, 2024	BUY	$10.11 - $16.54 $2,022 - $3,308	200 New	200 $0
Q2 2022 Aug 04, 2022	BUY	$9.11 - $13.98 $26,419 - $40,542	2,900 Added 263.64%	4,000 $6,000
Q4 2021 Jan 18, 2022	SELL	$7.7 - $37.13 $6,930 - $33,417	-900 Reduced 45.0%	1,100 $0
Q3 2021 Oct 26, 2021	SELL	$26.46 - $37.15 $391,608 - $549,820	-14,800 Reduced 88.1%	2,000 $2,000
Q2 2021 Jul 19, 2021	BUY	$32.73 - $47.95 $101,462 - $148,645	3,100 Added 22.63%	16,800 $9,000
Q1 2021 Apr 26, 2021	BUY	$40.39 - $56.73 $141,365 - $198,555	3,500 Added 34.31%	13,700 $66,000
Q4 2020 Jan 21, 2021	BUY	$51.77 - $66.18 $232,965 - $297,810	4,500 Added 78.95%	10,200 $44,000
Q3 2020 Oct 27, 2020	BUY	$43.8 - $58.16 $61,319 - $81,424	1,400 Added 32.56%	5,700 $14,000
Q2 2020 Jul 22, 2020	SELL	$37.05 - $65.03 $477,944 - $838,887	-12,900 Reduced 75.0%	4,300 $42,000
Q1 2020 May 07, 2020	SELL	$33.63 - $69.4 $1.67 Million - $3.44 Million	-49,600 Reduced 74.25%	17,200 $29,000
Q4 2019 Feb 06, 2020	BUY	$31.7 - $69.93 $2.11 Million - $4.66 Million	66,600 Added 33300.0%	66,800 $521,000
Q2 2019 Aug 09, 2019	BUY	$21.05 - $26.21 $4,210 - $5,242	200 New	200 $0

343K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.